The caveat to IV glutathione is that it has the highest risk of side effects
Novel and Emerging Therapies Include: CHIVA , a French acronym for conservative hemodynamic cure for venous insufficiency, is unique among venous disease treatments in that it preserves rather than destroys superficial veins
Treatment benefits fade rapidly, with only 6.2% of patients maintaining effects at 6 months post-treatment
Clinical trial participants reported better physical function, increased energy levels, reduced joint pain, and improved mental health scores
If it is used with insulin or a sulfonylurea, low blood sugar risk may increase, so other therapy amounts may need careful adjustment by the care team
Am J Clin Dermatol 13(1):4954